Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) Short Interest Update

Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) was the recipient of a significant decline in short interest in the month of May. As of May 15th, there was short interest totaling 2,710 shares, a decline of 52.3% from the April 30th total of 5,686 shares. Based on an average trading volume of 2,016 shares, the short-interest ratio is presently 1.3 days. Approximately 0.1% of the company’s shares are short sold.

Aimei Health Technology Trading Up 0.2%

NASDAQ:AFJK traded up $0.09 during mid-day trading on Monday, hitting $42.09. The company had a trading volume of 633 shares, compared to its average volume of 21,302. The business has a fifty day simple moving average of $38.78 and a 200-day simple moving average of $38.66. Aimei Health Technology has a 1 year low of $6.75 and a 1 year high of $130.37. The firm has a market capitalization of $133.42 million, a price-to-earnings ratio of 233.83 and a beta of 0.23.

Aimei Health Technology (NASDAQ:AFJK) last released its quarterly earnings data on Monday, May 4th. The company reported $0.02 EPS for the quarter.

Institutional Trading of Aimei Health Technology

Large investors have recently modified their holdings of the business. Jane Street Group LLC acquired a new stake in shares of Aimei Health Technology during the fourth quarter valued at about $302,000. Dakota Wealth Management acquired a new stake in shares of Aimei Health Technology during the fourth quarter valued at about $406,000. Geode Capital Management LLC acquired a new stake in shares of Aimei Health Technology during the fourth quarter valued at about $413,000. Clear Street Group Inc. acquired a new stake in shares of Aimei Health Technology during the third quarter valued at about $691,000. Finally, Quarry LP grew its stake in shares of Aimei Health Technology by 6.4% during the third quarter. Quarry LP now owns 167,081 shares of the company’s stock valued at $1,891,000 after acquiring an additional 10,000 shares in the last quarter. 45.58% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “sell (d+)” rating on shares of Aimei Health Technology in a research report on Friday, March 27th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock has a consensus rating of “Sell”.

About Aimei Health Technology

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co, Ltd was incorporated in 2023 and is based in New York, New York.